Benzinga | Jul 12, 2021 07:50AM EDT

Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $135

Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $125 to $135.